Effect of Resveratrol on Reactive Oxygen Species-Induced Cognitive Impairment in Rats with Angiotensin II-Induced Early Alzheimer’s Disease †

The protective effect of resveratrol on vascular aging by modulation of the renin–angiotensin system

(2018) Eun Nim Kim et al.   ATHEROSCLEROSIS

The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?

(2018) Patrick Gavin Kehoe   JOURNAL OF ALZHEIMERS DISEASE

Resveratrol regulates blood pressure by enhancing AMPK signaling to downregulate a Rac1-derived NADPH oxidase in the central nervous system

(2018) Tung-Chen Yeh et al.   JOURNAL OF APPLIED PHYSIOLOGY

Stimulation of ACE2/ANG(1–7)/Mas Axis by Diminazene Ameliorates Alzheimer’s Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway

(2018) Ahmed S. Kamel et al.   MOLECULAR NEUROBIOLOGY

Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity

(2018) Jee Hyun Yi et al.   NEUROPHARMACOLOGY

Drop coating deposition of a liposome suspension on surfaces with different wettabilities: “coffee ring” formation and suspension preconcentration

(2017) Eva Kočišová et al.   PHYSICAL CHEMISTRY CHEMICAL PHYSICS

Sirtuins as Novel Targets for Alzheimer's Disease and Other Neurodegenerative Disorders: Experimental and Genetic Evidence

(2017) Diego Albani et al.   JOURNAL OF ALZHEIMERS DISEASE

Tau and tauopathies

(2016) Thomas Arendt et al.   BRAIN RESEARCH BULLETIN

Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer';s Disease

(2016) Nady Braidy et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Energy metabolism and inflammation in brain aging and Alzheimer’s disease

(2016) Fei Yin et al.   FREE RADICAL BIOLOGY AND MEDICINE

Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress

(2016) Mohammed Ragab Abdel-Aziz Ali et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology

(2016) Patrick Gavin Kehoe et al.   Alzheimers Research & Therapy

p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice

(2016) Hai-long Dai et al.   Scientific Reports

Resveratrol Inhibition of Rac1-Derived Reactive Oxygen Species by AMPK Decreases Blood Pressure in a Fructose-Induced Rat Model of Hypertension

(2016) Pei-Wen Cheng et al.   Scientific Reports

Hypertension: Renin-Angiotensin-Aldosterone System Alterations

(2015) L. te Riet et al.   CIRCULATION RESEARCH

Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis

(2015) R. Ye et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP

(2015) Giuseppe Faraco et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Angiotensin and neurovascular coupling: beyond hypertension

(2015) Sherri Bloch et al.   MICROCIRCULATION

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

(2015) R. Scott Turner et al.   NEUROLOGY

Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer’s Disease

(2015) Fabian A. Cabezas-Opazo et al.   Oxidative Medicine and Cellular Longevity

Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape

(2015) Antero Salminen et al.   PROGRESS IN NEUROBIOLOGY

The Role of Oxidative Stress in Neurodegenerative Diseases

(2015) Geon Ha Kim et al.   Experimental Neurobiology

The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway

(2014) Yu-Jen Chang et al.   FEBS Journal

Aliskiren in early postnatal life prevents hypertension and reduces asymmetric dimethylarginine in offspring exposed to maternal caloric restriction

(2014) Chien-Ning Hsu et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

(2013) Xinglong Wang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

(2013) Emma Louise Ashby et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Neuroprotective Effects of Resveratrol Against Aβ Administration in Rats are Improved by Lipid-Core Nanocapsules

(2013) Rudimar L. Frozza et al.   MOLECULAR NEUROBIOLOGY

A model for improving the treatment and care of Alzheimer's disease patients through interdisciplinary research

(2012) John Q. Trojanowski et al.   Alzheimers & Dementia

Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains

(2012) Minjie Tian et al.   FEBS LETTERS

Resveratrol modulates astroglial functions: neuroprotective hypothesis

(2011) André Quincozes-Santos et al.   Annals of the New York Academy of Sciences

Neuroprotective properties of resveratrol and derivatives

(2011) Tristan Richard et al.   Annals of the New York Academy of Sciences

Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease

(2011) Jaewon Chang et al.   NEUROBIOLOGY OF AGING

Inorganic nitrite and chronic tissue ischaemia: a novel therapeutic modality for peripheral vascular diseases

(2010) C. B. Pattillo et al.   CARDIOVASCULAR RESEARCH

Angiotensin II Inhibits Neuronal Nitric Oxide Synthase Activation Through the ERK1/2-RSK Signaling Pathway to Modulate Central Control of Blood Pressure

(2010) Wen-Han Cheng et al.   CIRCULATION RESEARCH

AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism

(2010) Valérie Vingtdeux et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers

(2010) Ali Reza A. Ladiwala et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Involvement of Brain-Derived Neurotrophic Factor and Neurogenesis in Oestradiol Neuroprotection of the Hippocampus of Hypertensive Rats

(2010) L. Pietranera et al.   JOURNAL OF NEUROENDOCRINOLOGY

Changes induced by a fructose-rich diet on hepatic metabolism and the antioxidant system

(2010) Flavio Francini et al.   LIFE SCIENCES

Alzheimer disease: Time to improve its diagnosis and treatment

(2009) S. SALLOWAY et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Opportunities and limitations of genetic analysis of hypertensive rat strains

(2009) Juan M Saavedra   JOURNAL OF HYPERTENSION

Resveratrol bioavailability and toxicity in humans

(2009) Charles-Henry Cottart et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation

(2009) Ying Feng et al.   NEUROTOXICOLOGY

SIRT1, a Longevity Gene, Downregulates Angiotensin II Type 1 Receptor Expression in Vascular Smooth Muscle Cells

(2008) Ryohei Miyazaki et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Hypertension and Cognitive Function

(2008) Cristina Paglieri et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION